Literature DB >> 19473979

Docking of PRAK/MK5 to the atypical MAPKs ERK3 and ERK4 defines a novel MAPK interaction motif.

Espen Aberg1, Knut Martin Torgersen, Bjarne Johansen, Stephen M Keyse, Maria Perander, Ole-Morten Seternes.   

Abstract

ERK3 and ERK4 are atypical MAPKs in which the canonical TXY motif within the activation loop of the classical MAPKs is replaced by SEG. Both ERK3 and ERK4 bind, translocate, and activate the MAPK-activated protein kinase (MK) 5. The classical MAPKs ERK1/2 and p38 interact with downstream MKs (RSK1-3 and MK2-3, respectively) through conserved clusters of acidic amino acids, which constitute the common docking (CD) domain. In contrast to the classical MAPKs, the interaction between ERK3/4 and MK5 is strictly dependent on phosphorylation of the SEG motif of these kinases. Here we report that the conserved CD domain is dispensable for the interaction of ERK3 and ERK4 with MK5. Using peptide overlay assays, we have defined a novel MK5 interaction motif (FRIEDE) within both ERK4 and ERK3 that is essential for binding to the C-terminal region of MK5. This motif is located within the L16 extension lying C-terminal to the CD domain in ERK3 and ERK4 and a single isoleucine to lysine substitution in FRIEDE totally abrogates binding, activation, and translocation of MK5 by both ERK3 and ERK4. These findings are the first to demonstrate binding of a physiological substrate via this region of the L16 loop in a MAPK. Furthermore, the link between activation loop phosphorylation and accessibility of the FRIEDE interaction motif suggests a switch mechanism for these atypical MAPKs in which the phosphorylation status of the activation loop regulates the ability of both ERK3 and ERK4 to bind to a downstream effector.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19473979      PMCID: PMC2740564          DOI: 10.1074/jbc.M109.023283

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  41 in total

Review 1.  ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions.

Authors:  Philippe P Roux; John Blenis
Journal:  Microbiol Mol Biol Rev       Date:  2004-06       Impact factor: 11.056

2.  Regulation of MAPK-activated protein kinase 5 activity and subcellular localization by the atypical MAPK ERK4/MAPK4.

Authors:  Espen Aberg; Maria Perander; Bjarne Johansen; Catherine Julien; Sylvain Meloche; Stephen M Keyse; Ole-Morten Seternes
Journal:  J Biol Chem       Date:  2006-09-13       Impact factor: 5.157

3.  Characterization of the atypical MAPK ERK4 and its activation of the MAPK-activated protein kinase MK5.

Authors:  Shashi Kant; Stefanie Schumacher; Manvendra Kumar Singh; Andreas Kispert; Alexey Kotlyarov; Matthias Gaestel
Journal:  J Biol Chem       Date:  2006-09-13       Impact factor: 5.157

Review 4.  MAP kinase pathways.

Authors:  Maosong Qi; Elaine A Elion
Journal:  J Cell Sci       Date:  2005-08-15       Impact factor: 5.285

Review 5.  MAPKAP kinases - MKs - two's company, three's a crowd.

Authors:  Matthias Gaestel
Journal:  Nat Rev Mol Cell Biol       Date:  2006-02       Impact factor: 94.444

Review 6.  MAP kinase pathways: the first twenty years.

Authors:  Joseph Avruch
Journal:  Biochim Biophys Acta       Date:  2006-11-15

Review 7.  MAP kinases and the control of nuclear events.

Authors:  A G Turjanski; J P Vaqué; J S Gutkind
Journal:  Oncogene       Date:  2007-05-14       Impact factor: 9.867

8.  Identification of novel point mutations in ERK2 that selectively disrupt binding to MEK1.

Authors:  Fred L Robinson; Angelique W Whitehurst; Malavika Raman; Melanie H Cobb
Journal:  J Biol Chem       Date:  2002-01-31       Impact factor: 5.157

9.  Both binding and activation of p38 mitogen-activated protein kinase (MAPK) play essential roles in regulation of the nucleocytoplasmic distribution of MAPK-activated protein kinase 5 by cellular stress.

Authors:  Ole Morten Seternes; Bjarne Johansen; Beate Hegge; Mona Johannessen; Stephen M Keyse; Ugo Moens
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

10.  JNK2 contains a specificity-determining region responsible for efficient c-Jun binding and phosphorylation.

Authors:  T Kallunki; B Su; I Tsigelny; H K Sluss; B Dérijard; G Moore; R Davis; M Karin
Journal:  Genes Dev       Date:  1994-12-15       Impact factor: 11.361

View more
  22 in total

1.  IGF2BP1 promotes cell migration by regulating MK5 and PTEN signaling.

Authors:  Nadine Stöhr; Marcel Köhn; Marcell Lederer; Markus Glass; Claudia Reinke; Robert H Singer; Stefan Hüttelmaier
Journal:  Genes Dev       Date:  2012-01-15       Impact factor: 11.361

2.  Physiological roles of mitogen-activated-protein-kinase-activated p38-regulated/activated protein kinase.

Authors:  Sergiy Kostenko; Gianina Dumitriu; Kari Jenssen Lægreid; Ugo Moens
Journal:  World J Biol Chem       Date:  2011-05-26

Review 3.  Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases.

Authors:  Marie Cargnello; Philippe P Roux
Journal:  Microbiol Mol Biol Rev       Date:  2011-03       Impact factor: 11.056

4.  Identification of the atypical MAPK Erk3 as a novel substrate for p21-activated kinase (Pak) activity.

Authors:  Alina De la Mota-Peynado; Jonathan Chernoff; Alexander Beeser
Journal:  J Biol Chem       Date:  2011-02-11       Impact factor: 5.157

5.  ERK3/MAPK6 controls IL-8 production and chemotaxis.

Authors:  Katarzyna Bogucka; Malvika Pompaiah; Federico Marini; Harald Binder; Gregory Harms; Manuel Kaulich; Matthias Klein; Christian Michel; Markus P Radsak; Sebastian Rosigkeit; Peter Grimminger; Hansjörg Schild; Krishnaraj Rajalingam
Journal:  Elife       Date:  2020-04-21       Impact factor: 8.140

6.  Germ Line Deletion Reveals a Nonessential Role of Atypical Mitogen-Activated Protein Kinase 6/Extracellular Signal-Regulated Kinase 3.

Authors:  A Kotlyarov; M Gaestel; N Ronkina; K Schuster-Gossler; F Hansmann; H Kunze-Schumacher; I Sandrock; T Yakovleva; J Lafera; W Baumgärtner; A Krueger; I Prinz; A Gossler
Journal:  Mol Cell Biol       Date:  2019-03-01       Impact factor: 4.272

Review 7.  The discovery of novel experimental therapies for inflammatory arthritis.

Authors:  Charles J Malemud
Journal:  Mediators Inflamm       Date:  2010-03-18       Impact factor: 4.711

8.  MAPK4 overexpression promotes tumor progression via noncanonical activation of AKT/mTOR signaling.

Authors:  Wei Wang; Tao Shen; Bingning Dong; Chad J Creighton; Yanling Meng; Wolong Zhou; Qing Shi; Hao Zhou; Yinjie Zhang; David D Moore; Feng Yang
Journal:  J Clin Invest       Date:  2019-01-28       Impact factor: 14.808

9.  The extracellular signal-regulated kinase 3 (mitogen-activated protein kinase 6 [MAPK6])-MAPK-activated protein kinase 5 signaling complex regulates septin function and dendrite morphology.

Authors:  Frank Brand; Stefanie Schumacher; Shashi Kant; Manoj B Menon; Ruth Simon; Benjamin Turgeon; Stefan Britsch; Sylvain Meloche; Matthias Gaestel; Alexey Kotlyarov
Journal:  Mol Cell Biol       Date:  2012-04-16       Impact factor: 4.272

10.  Tumour promoting and suppressing roles of the atypical MAP kinase signalling pathway ERK3/4-MK5.

Authors:  Sergiy Kostenko; Gianina Dumitriu; Ugo Moens
Journal:  J Mol Signal       Date:  2012-07-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.